Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Karyopharm Therapeutics (KPTI) Q1 2026 Earnings
KPTI
12
Feb
Confirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-5.71
-4.47
-3.23
-1.99
Details
Expected EPS
-1.994286
Actual EPS
-5.71
Surprise EPS
-3.72
Surprise Percent
+186.32%
Description
Karyopharm Therapeutics (KPTI) has reported earnings of -5.71 per share for Q1 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login